In this study, we aimed to investigate miRNAs targeting HIF-2α, VEGFR1 and VEGFR2 in m-ccRCC as potential predictive biomarkers for treatment efficacy of anti-angiogenic therapies in m-ccRCC. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.